medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2025, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2025; 42 (1)

Guillain Barre Syndrome in pediatric patients in Mexico. Epidemiological characteristics and geographical distribution

Bojorquez-Bustamante A, Durán-De la Re A, Perez MGD

Language: Spanish
References: 19
Page: 7-16
PDF size: 639.73 Kb.


ABSTRACT

Introduction: Guillain-Barre syndrome (GBS) is the most common cause of flaccid paralysis in the world. It is considered a severe post-infectious immune-mediated neuropathy.
Objectives: Describe and compare the epidemiological, clinical behavior and evolution of GBS in Mexico by regions of the National Health and Nutrition Survey (ENSANUT 2021).
Material and methods: This is a descriptive and retrospective study. Variables: age, sex, season of the year, incidence and mortality.
Results: Schoolchildren predominated 26.18%, males 60.53%. 31.60% of the cases were in summer. Higher incidence in the Northern Pacific Region with 2.67/100,000 inhabitants-year. The year 2019 had the highest national incidence and mortality: incidence of 1.83/100,000 inhabitants-year and mortality of 0.36/1,000,000 inhabitants-year.
Discussion: An increase in incidence stands out in the Northern Pacific Region compared to the rest of the country; these states share sociodemographic and climatic characteristics, associating the number of cases with gastrointestinal infections, since the behavior was seasonal in summer.
Conclusion: It is necessary to carry out more studies to understand the etiology of GBS and risk factors in these regions, to regulate public health behaviors and reduce the number of cases.


REFERENCES

  1. Juan Carlos López-Hernández, Javier AndrésGalnares-Olalde, Gutiérrez A, Estrada SA, García-Grimshaw M, Edwin Steven Vargas-Cañas.Guillain-Barre syndrome in Mexico: clinical featuresand validation of Brighton Collaboration Group criteria.PubMed. 2022 Apr 16;74(8):258–64.

  2. Nguyen TP, Taylor RS. Guillain barre syndrome [Internet].Nih.gov. StatPearls Publishing;2023. Availablefrom: https://www.ncbi.nlm.nih.gov/books/NBK532254/

  3. Sederholm B. Treatment of Acute Immune-mediatedNeuropathies: Guillain Barré Syndrome andClinical Variants. Seminars in Neurology. 2010 Sep;30(04):365–72.

  4. Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. The Lancet. 2021 Mar27;397(10280):1214–28.

  5. Anchatuña JRM, Toasa AGN, U MR. Síndrome deGuillan-Barré: diagnóstico y tratamiento de unaneuropatía inmunomediada. Journal of AmericanHealth [Internet]. 2023 Feb 24;6(1). Available from:https://jah-journal.com/index.php/jah/article/view/168/322

  6. Carrera García L, María J, Escudero E, Natera DeBenito D, Ortez C, Nascimento A, et al. Neuropatíashereditarias y síndrome de Guillain-Barré [Internet].Available from: https://www.aeped.es/sites/default/files/documentos/21.pdf

  7. Van Doorn PA. Diagnosis, treatment and prognosisof Guillain-Barré syndrome (GBS). La PresseMédicale. 2013 Jun;42(6):e193–201.

  8. J.C. López Hernández, Pompa AM, Torres TP, AndrésJ, Cañas SV. Eficacia del uso de prednisonacomo terapia a largo plazo en pacientes con polineuropatíadesmielinizante inflamatoria crónica(PDIC): una cohorte retrospectiva. Revista deBol Clin Hosp Infant Edo Son 2025; 42 (1); 17- 23neurología [Internet]. 2021;73(8):275–81. Availablefrom: https://dialnet.unirioja.es/servlet/articulo?codigo=8159390

  9. De la Fuente-Silva FM, De la Fuente-Silva JA, Silva-Ramírez MA, et al. Síndrome de Guillain-Barrépediátrico en México características clínicas antesy durante la pandemia de SARS-COV-2. Arch Neurocien(Mex). 2023 Sept; 29.

  10. Durán De La Re A, Fonseca-Chon I, Sotelo-Cruz N,Sotelo Cruz N. Arch Neurocien ( Mex ) INNN, 2016 Guillain-Barré syndrome. Experience with91 Children at a Pediatric Hospital in NorthwesternMexico [Internet]. [cited 2025 Apr 2]. Available from:https://www.medigraphic.com/pdfs/arcneu/ane-2016/ane161a.pdf

  11. Reynaldo A, Ramírez P, Minerva López Quiroz G,En M, Yenifeer A, Domínguez L, et al. ComisiónNacional del Agua Coordinación General del ServicioMeteorológico Nacional [Internet]. [cited 2025Apr 2]. Available from: https://smn.conagua.gob.mx/tools/DATA/Climatolog%C3%ADa/Diagn%-C3%B3stico%20Atmosf%C3%A9rico/Reporte%20del%20Clima%20en%20M%C3%A9xico/RC-Junio24.pdf

  12. Trujillo Gittermann LM, Valenzuela Feris SN, vonOetinger Giacoman A. Relación entre COVID-19 ysíndrome de Guillain-Barré en adultos. Revisión sistemática.Neurología. 2020 Jul.

  13. Expósito J, Carrera L, Natera D, Nolasco G, NascimentoA, Ortez C. ARTÍCULO ESPECIAL -REVISIÓNSÍNDROME DE GUILLAIN-BARRÉ Y OTRAS NEUROPATÍASAUTOINMUNES: TRATAMIENTO ACTUAL[Internet]. Available from: https://www.medicinabuenosaires.com/revistas/vol82-22/s3/82s3.pdf

  14. Del Carpio-Orantes L. Síndrome de GuillainBarrédurante los brotes arbovirales en México. Med IntMéx 2022; 38 (4): 820-824.

  15. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, etal. Nervous system involvement after infection withCOVID-19 and other coronaviruses. Brain, Behavior,and Immunity [Internet]. 2020 Mar 30;87:18-22.Available from: https://www.sciencedirect.com/science/article/pii/S0889159120303573?via%3Dihub

  16. García-Grimshaw M, Ceballos-Liceaga SE, Hernández-Vanegas LE, Núñez I, Hernández-ValdiviaN, Carrillo-García DA, et al. Neurologic adverseevents among 704,003 first-dose recipients of theBNT162b2 mRNA COVID-19 vaccine in Mexico: Anationwide descriptive study. Clinical Immunology.2021 Aug;229:108786.

  17. Morales, Ó. P. Actualización en el Síndrome deGuillain-Barré. Revista Médica Sinergia. 2019 Nov;4(11).

  18. Fujimura H. The Guillain-Barré syndrome. Handbookof Clinical Neurology [Internet]. 2013;115:383–402. Available from: https://pubmed.ncbi.nlm.nih.gov/23931791/

  19. Leonhard SE, Mandarakas MR, Gondim FAA, BatemanK, Ferreira MLB, Cornblath DR, et al. Diagnosisand management of Guillain–Barré syndrome inten steps. Nature Reviews Neurology. 2019;15(11).




2020     |     www.medigraphic.com